Type 2 cGMP-dependent protein kinase regulates homeostasis by blocking c-Jun N-terminal kinase in the colon epithelium

Cell Death and Differentiation

Volumn 21, Issue 3, 2014, Pages 427-437

  Wang, R ^a   Kwon, I K ^a   Singh, N ^a   Islam, B ^a   Liu, K ^a   Sridhar, S ^a   Hofmann, F ^b   Browning, D D ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

cGMP; colon; DUSP10; JNK; PKG2

Indexed keywords

CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE 2; IMIDAZOLE DERIVATIVE; MUC2 PROTEIN, HUMAN; MUCIN 2; PIPERAZINE DERIVATIVE; PRKG2 PROTEIN, MOUSE; STRESS ACTIVATED PROTEIN KINASE; SULFONE; TRIAZINE DERIVATIVE; VARDENAFIL;

ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; BIOSYNTHESIS; CACO 2 CELL LINE; CELL DIFFERENTIATION; CELL GROWTH; COLON; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; EPITHELIUM CELL; GENETICS; GOBLET CELL; HOMEOSTASIS; HUMAN; KNOCKOUT MOUSE; MALE; METABOLISM; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CACO-2 CELLS; CELL DIFFERENTIATION; CELL GROWTH PROCESSES; COLON; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASE TYPE II; EPITHELIAL CELLS; GOBLET CELLS; HOMEOSTASIS; HUMANS; IMIDAZOLES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, KNOCKOUT; MUCIN-2; PIPERAZINES; SULFONES; TRIAZINES;

EID: 84893824487     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2013.163     Document Type: Article

References (35)

1. Forte LR Jr. Uroguanylin and guanylin peptides: Oharmacology and experimental therapeutics. Pharmacol Ther 2004; 104: 137-162
2. Steinbrecher KA, Cohen MB. Transmembrane guanylate cyclase in intestinal pathophysiology. Curr Opin Gastroenterol 2011; 27: 139-145
3. Lucas KA, Pitari GM, Kazerounian S, Ruiz-Stewart I, Park J, Schulz S et al. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 2000; 52: 375-414
4. Markert T, Vaandrager AB, Gambaryan S, Pohler D, Hausler C, Walter U et al. Endogenous expression of type II cGMP-dependent protein kinase mRNA and protein in rat intestine. Implications for cystic fibrosis transmembrane conductance regulator. J Clin Invest 1995; 96: 822-830
5. Pfeifer A, Aszodi A, Seidler U, Ruth P, Hofmann F, Fassler R. Intestinal secretory defects and dwarfism in mice lacking cGMP-dependent protein kinase II. Science 1996; 274: 2082-2086
6. Simons BD, Clevers H. Stem cell self-renewal in intestinal crypt. Exp Cell Res 2011; 317: 2719-2724
7. Medema JP, Vermeulen L. Microenvironmental regulation of stem cells in intestinal homeostasis and cancer. Nature 2011; 474: 318-326
8. Li P, Lin JE, Chervoneva I, Schulz S, Waldman SA, Pitari GM. Homeostatic control of the crypt-villus axis by the bacterial enterotoxin receptor guanylyl cyclase C restricts the proliferating compartment in intestine. Am J Pathol 2007; 171: 1847-1858
9. Steinbrecher KA, Wowk SA, Rudolph JA,Witte DP, Cohen MB. Targeted inactivation of the mouse guanylin gene results in altered dynamics of colonic epithelial proliferation. Am J Pathol 2002; 161: 2169-2178
10. Wang R, Kwon IK, Thangaraju M, Singh N, Liu K, Jay P et al. Type 2 cGMP-dependent protein kinase regulates proliferation and differentiation in the colonic mucosa. Am J Physiol Gastrointest Liver Physiol 2012; 303: G209-G219
11. Li P, Schulz S, Bombonati A, Palazzo JP, Hyslop TM, Xu Y et al. Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity. Gastroenterology 2007; 133: 599-607
12. Garin-Laflam MP, Steinbrecher KA, Rudolph JA, Mao J, Cohen MB. Activation of guanylate cyclase C signaling pathway protects intestinal epithelial cells from acute radiation-induced apoptosis. Am J Physiol Gastrointest Liver Physiol 2009; 296: G740-G749
13. Han X, Mann E, Gilbert S, Guan Y, Steinbrecher KA, Montrose MH et al. Loss of guanylyl cyclase C (GCC) signaling leads to dysfunctional intestinal barrier. PLoS One 2011; 6: E16139
14. Lin JE, Snook AE, Li P, Stoecker BA, Kim GW, Magee MS et al. GUCY2C opposes systemic genotoxic tumorigenesis by regulating AKT-dependent intestinal barrier integrity. PLoS One 2012; 7: E31686
15. Lin JE, Li P, Snook AE, Schulz S, Dasgupta A, Hyslop TM et al. The hormone receptor GUCY2C suppresses intestinal tumor formation by inhibiting AKT signaling. Gastroenterology 2010; 138: 241-254
16. Tanoue T, Moriguchi T, Nishida E. Molecular cloning and characterization of a novel dual specificity phosphatase, MKP-5. J Biol Chem 1999; 274: 19949-19956
17. Theodosiou A, Smith A, Gillieron C, Arkinstall S, Ashworth A. MKP5, a new member of the MAP kinase phosphatase family, which selectively dephosphorylates stress-Activated kinases. Oncogene 1999; 18: 6981-6988
18. Blache P, van de Wetering M, Duluc I, Domon C, Berta P, Freund JN et al. SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes. J Cell Biol 2004; 166: 37-47
19. Dhanasekaran DN, Reddy EP. JNK signaling in apoptosis. Oncogene 2008; 27: 6245-6251
20. Sancho R, Nateri AS, de Vinuesa AG, Aguilera C, Nye E, Spencer-Dene B et al. JNK signalling modulates intestinal homeostasis and tumourigenesis in mice. EMBO J 2009; 28: 1843-1854
21. Wirtz S, Neufert C, Weigmann B, Neurath MF. Chemically induced mouse models of intestinal inflammation. Nat Protoc 2007; 2: 541-546
22. Lee HY, Crawley S, Hokari R, Kwon S, Kim YS. Bile acid regulates MUC2 transcription in colon cancer cells via positive EGFR/PKC/Ras/ERK/CREB, PI3K/Akt/IkappaB/NF-kappaB and p38/MSK1/CREB pathways and negative JNK/c-Jun/AP-1 pathway. Int J Oncol 2010; 36: 941-953
23. Ahn DH, Crawley SC, Hokari R, Kato S, Yang SC, Li JD et al. TNF-Alpha activates MUC2 transcription via NF-kappaB but inhibits via JNK activation. Cell Physiol Biochem 2005; 15: 29-40
24. Li Y, Kundu P, Seow SW, de Matos CT, Aronsson L, Chin KC et al. Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APCMin/' mice. Carcinogenesis 2012; 33: 1231-1238
25. Golin-Bisello F, Bradbury N, Ameen N. STa and cGMP stimulate CFTR translocation to the surface of villus enterocytes in rat jejunum and is regulated by protein kinase G. Am J Physiol Cell Physiol 2005; 289: C708-C716
26. Apidianakis Y, Pitsouli C, Perrimon N, Rahme L. Synergy between bacterial infection and genetic predisposition in intestinal dysplasia. Proc Natl Acad Sci USA 2009; 106: 20883-20888
27. Assi K, Pillai R, Gomez-Munoz A, Owen D, Salh B. The specific JNK inhibitor SP600125 targets tumour necrosis factor-Alpha production and epithelial cell apoptosis in acute murine colitis. Immunology 2006; 118: 112-121
28. Karin M, Gallagher E. From JNK to pay dirt: Jun kinases, their biochemistry, physiology and clinical importance. IUBMB Life 2005; 57: 283-295
29. Waetzig GH, Seegert D, Rosenstiel P, Nikolaus S, Schreiber S. p38 mitogen-Activated protein kinase is activated and linked to TNF-Alpha signaling in inflammatory bowel disease. J Immunol 2002; 168: 5342-5351
30. Vereecke L, Beyaert R, van Loo G. Enterocyte death and intestinal barrier maintenance in homeostasis and disease. Trends Mol Med 2011; 17: 584-593
31. Vaandrager AB, Bot AG, Ruth P, Pfeifer A, Hofmann F, De Jonge HR. Differential role of cyclic GMP-dependent protein kinase II in ion transport in murine small intestine and colon. Gastroenterology 2000; 118: 108-114
32. Shailubhai K, Yu HH, Karunanandaa K, Wang JY, Eber SL, Wang Y et al. Uroguanylin treatment suppresses polyp formation in the Apc(Min/') mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP. Cancer Res 2000; 60: 5151-5157
33. Francis SH, Sekhar KR, Ke H, Corbin JD. Inhibition of cyclic nucleotide phosphodiesterases by methylxanthines and related compounds. Handb Exp Pharmacol 2011; 200: 93-133
34. Kwon IK, Wang R, Thangaraju M, Shuang H, Liu K, Dashwood R et al. PKG inhibits TCF signaling in colon cancer cells by blocking beta-catenin expression and activating FOXO4. Oncogene 2010; 9: 3423-3434
35. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993; 69: 238-249